Fluorine F 18 RD2
Term · Oncology and biomedicine · MLC-T-ONC-013696
A radioconjugate composed of the amyloid-beta-binding peptide RD2 labeled with the radionuclide fluorine F 18, with potential amyloid-beta peptide imaging activity upon positron emission topography (PET)/computed tomography (CT). Upon administration of fluorine F 18 RD2, RD2 targets and binds to amyloid-beta. Upon PET/CT imaging, amyloid-beta plaques can be visualized and detected. Amyloid-beta is a key component in plaque formation in Alzheimer's disease. Elevated plasma levels of amyloid-beta are also associated with some cancers.
| Identifier | MLC-T-ONC-013696 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 18F RD2; 18F-RD2; 18F-labeled RD2 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013696",
"term": "Fluorine F 18 RD2",
"field": "Oncology and biomedicine",
"definition": "A radioconjugate composed of the amyloid-beta-binding peptide RD2 labeled with the radionuclide fluorine F 18, with potential amyloid-beta peptide imaging activity upon positron emission topography (PET)/computed tomography (CT). Upon administration of fluorine F 18 RD2, RD2 targets and binds to amyloid-beta. Upon PET/CT imaging, amyloid-beta plaques can be visualized and detected. Amyloid-beta is a key component in plaque formation in Alzheimer's disease. Elevated plasma levels of amyloid-beta are also associated with some cancers.",
"synonyms": [
"18F RD2",
"18F-RD2",
"18F-labeled RD2"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/fluorine-f-18-rd2/"
}
Record 7,445 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.